Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miconazole vs Hydroquinone in Melasma
NCT01661556Phase 4Unknown
- Sponsor
- Universidad Autónoma de San Luis Potosí
- Start
- Oct 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of miconazole in melasma (3 arms), sponsored by Universidad Autónoma de San Luis Potosí. Primary endpoint: Depigmentation of melasma lesions by Colorimetry at 12 weeks. Status: unknown.
02
Drugs
miconazole
03
Conditions
melasma
Beyond the preview
Go deeper on NCT01661556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661556.